Join Our Network

HOW you CAN HELP

Answer the Call to Help Our Nation's Finest

Join the TreatOSA4VA network bringing Oral Appliance Therapy to veterans across the country. Out providers receive patient referrals with sleep tests, diagnosis and prescriptions from VA Medical Centers. The TreatOSA4VA workflow is streamlined with predictable reimbursement. Join now to save lives. 

How to Join

Get Started

Fill out the form below to begin the credentialing process. 

    Check Status

    Request Update

    Fill out the form below to request a credentialing status update. 

      Refer a Patient

      Questions? Contact us for more information

        References

        1.When adherence is defined as greater than 4 hours of nightly use, 46 to 83% of patients with obstructive sleep apnea have been reported to be nonadherent to treatment. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 5:173.
        2.The objective mean use rate was 6.4 +- 1.7 h/night at 1 year follow-up in continuing users, with a regular use rate of 83%. Dieltjens M, Braem MJ, Vroegop AVMT, Wouters K, Verbraecken JA, De Backer WA, Van de Heyning PH, Vanderveken OM. Chest. 2013 Nov;144(5):1495-1502. doi: 10.1378/chest.13-0613.
        3. Head-to-head trials confirm CPAP is superior in reducing OSA parameters on polysomnography; however, this greater efficacy does not necessarily translate into better health outcomes in clinical practice. Comparable effectiveness of OAm and CPAP has been attributed to higher reported nightly use of OAm, . Sutherland K, Vanderveken OM, Tsuda H, Marklund M, Gagnadoux F, Kushida CA, Cistulli PA, Oral Appliance Treatment for Obstructive Sleep Apnea: An Update. J Clin Sleep Med. 2014 Feb 15; 10(2): 215–227.
        4. Tegelberg A, Wilhelmsson B, Erixon-Lindroth N, Lindström LH. Improved cognitive functions after treatment with an oral appliance in obstructive sleep apnea. Nat Sci Sleep. 2012 Aug 22;4:89-96. doi: 10.2147/NSS.S33849. PMID: 23620682; PMCID: PMC3630975.
        5. Rangarajan H, Padmanabhan S, Ranganathan S, Kailasam V. Impact of oral appliance therapy on quality of life (QoL) in patients with obstructive sleep apnea – a systematic review and meta-analysis. Sleep Breath. 2022 Sep;26(3):983-996. doi: 10.1007/s11325-021-02483-0. Epub 2021 Sep 13. PMID: 34515959.
        6. Iftikhar IH, Hays ER, Iverson MA, Magalang UJ, Maas AK. Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med. 2013 Feb 1;9(2):165-74. doi: 10.5664/jcsm.2420. PMID: 23372472; PMCID: PMC3544387.
        7. Lin, CC., Wang, HY., Chiu, CH. et al. Effect of oral appliance on endothelial function in sleep apnea. Clin Oral Invest 19, 437–444 (2015).
        8. Anandam A, Patil M, Akinnusi M, Jaoude P, El-Solh AA. Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: an observational study. Respirology. 2013 Nov;18(8):1184-90. doi: 10.1111/resp.12140. PMID: 23731062.
        9. Marklund M, Verbraecken J, Randerath W. Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy. Eur Respir J. 2012;39(5):1241–1247.
        10. Sutherland K; Vanderveken OM; Tsuda H; Marklund M; Gagnadoux F; Kushida CA; Cistulli PA; on behalf of the ORANGE-Registry. Oral appliance treatment for obstructive sleep apnea: an update. J Clin Sleep Med 2014;10(2):215-227.